Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy to treat Covid19.
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat Covid-19.
The first phase of the trial will test whether the therapy is safe and well-tolerated; those results are expected in late June. The first Covid-19 patients being treated with the therapy are hospitalized at New York University's Grossman School of Medicine in New York, Cedars-Sinai in Los Angeles and Emory University in Atlanta, the company told CNN.
"For many of us, this feels a little like a moonshot or a Manhattan Project, where so many scientists are working together at breakneck speeds," Skovronksy said."Surely there will be other advances that come of this."
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Eli Lilly starts human study of potential COVID-19 treatmentEli Lilly and Co said on Monday first set of patients have been dosed in an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.
Weiterlesen »
Eli Lilly starts human study of potential COVID-19 antibody treatmentEli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.
Weiterlesen »
Exclusive: Russia to roll out its first approved COVID-19 drug next weekRussia will start giving its first drug approved to treat COVID-19 to patients next week, its state financial backer told Reuters, a move it hopes will ease strains on the health system and speed a return to normal economic life.
Weiterlesen »
Hong Kong reports first local COVID-19 cases in two weeksHong Kong has confirmed its first locally transmitted coronavirus cases in more than two weeks, fuelling concerns over its spread as restrictions on movement are relaxed.
Weiterlesen »
South Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
Weiterlesen »